Patient Information
Age: 31
Sex: Male
Diagnosed: 6/99
Location: Germany
Diagnosis: Two large tumors in the abdomen (13 cm in left mesocolon and 8 cm between bladder and rectum) and infected lymph nodes. Stage IV DSRCT
Hospital:
- Oncologist
Current: In remission in report from August 2005.
Treatment
- Underwent radical surgery
- High-dose chemotherapy in combination with stem-cell transplantation
- Exact treatment
- a) 2 cycles VIP-E - Etoposide, Ifosfamide, Cisplatin, and Epirubicin (VIP-E)
- b) CCT High-dose chemotherapy with
- Cyclophosphamid 1500 mg/m2
- Carboplatin 200 mg/m2
- Thiotepa 125 mg/m2
- c) Stem cell transplantation with expanded stem cells (4 x 10*6 WBC)
Time Line
Date | Test | Treatment | Chemicals | Result |
---|---|---|---|---|
June 1999 | 0 | Surgery | 0 | 0 |
1999 | 0 | High Dose Chemo 1 | Etoposide, Ifosfamide, Cisplatin, and Epirubicin (VIP-E) | 0 |
1999 | 0 | High Dose Chemo 2 | Etoposide, Ifosfamide, Cisplatin, and Epirubicin (VIP-E) | 0 |
1999 | 0 | Stem Cell | Cyclophosphamid,Carboplatin,Thiotepa | 0 |
1999 | 0 | 0 | 0 | End Treatment |
1/00 | 0 | 0 | 0 | 0 |
1/01 | 0 | 0 | 0 | 0 |
1/02 | 0 | 0 | 0 | 0 |
1/03 | 0 | 0 | 0 | 0 |
1/04 | 0 | 0 | 0 | 0 |
1/05 | 0 | 0 | 0 | 0 |
1/06 | 0 | 0 | 0 | 0 |
2/06 | 0 | 0 | 0 | 0 |
3/06 | 0 | 0 | 0 | 0 |
4/06 | 0 | 0 | 0 | 0 |
5/06 | 0 | 0 | 0 | 0 |
6/06 | 0 | 0 | 0 | 0 |
7/06 | 0 | 0 | 0 | 0 |
8/06 | 0 | 0 | 0 | 0 |
9/06 | 0 | 0 | 0 | 0 |
10/06 | 0 | 0 | 0 | 0 |
11/06 | 0 | 0 | 0 | 0 |
12/06 | 0 | 0 | 0 | 0 |
1/07 | 0 | 0 | 0 | 0 |
2/07 | 0 | 0 | 0 | 0 |
3/07 | 0 | 0 | 0 | 0 |
4/07 | 0 | 0 | 0 | 0 |
5/07 | 0 | 0 | 0 | 0 |
6/07 | 0 | 0 | 0 | 0 |
7/07 | 0 | 0 | 0 | 0 |
8/07 | 0 | 0 | 0 | 0 |
9/07 | 0 | 0 | 0 | 0 |
10/07 | 0 | 0 | 0 | 0 |
11/07 | 0 | 0 | 0 | 0 |
12/07 | 0 | 0 | 0 | 0 |
1/08 | 0 | 0 | 0 | 0 |
2/08 | 0 | 0 | 0 | 0 |
3/08 | 0 | 0 | 0 | 0 |
4/08 | 0 | 0 | 0 | 0 |
5/08 | 0 | 0 | 0 | 0 |
6/08 | 0 | 0 | 0 | 0 |
7/08 | 0 | 0 | 0 | 0 |
8/08 | 0 | 0 | 0 | 0 |
9/08 | 0 | 0 | 0 | 0 |
10/08 | 0 | 0 | 0 | 0 |
11/08 | 0 | 0 | 0 | 0 |
12/08 | 0 | 0 | 0 | 0 |
1/09 | 0 | 0 | 0 | 0 |
2/09 | 0 | 0 | 0 | 0 |
3/09 | 0 | 0 | 0 | 0 |
4/09 | 0 | 0 | 0 | 0 |
5/09 | 0 | 0 | 0 | 0 |
6/09 | 0 | 0 | 0 | 0 |
7/09 | 0 | 0 | 0 | 0 |
8/09 | 0 | 0 | 0 | 0 |
9/09 | 0 | 0 | 0 | 0 |
10/09 | 0 | 0 | 0 | 0 |
11/09 | 0 | 0 | 0 | 0 |
12/09 | 0 | 0 | 0 | 0 |
1/10 | 0 | 0 | 0 | 0 |
2/10 | 0 | 0 | 0 | 0 |
3/10 | 0 | 0 | 0 | 0 |
4/10 | 0 | 0 | 0 | 0 |
5/10 | 0 | 0 | 0 | 0 |
6/10 | 0 | 0 | 0 | 0 |
7/10 | 0 | 0 | 0 | 0 |
8/10 | 0 | 0 | 0 | 0 |
9/10 | 0 | 0 | 0 | 0 |
10/10 | 0 | 0 | 0 | 0 |
11/10 | 0 | 0 | 0 | 0 |
12/10 | 0 | 0 | 0 | 0 |
1/11 | 0 | 0 | 0 | 0 |
2/11 | 0 | 0 | 0 | 0 |
3/11 | 0 | 0 | 0 | 0 |
4/11 | 0 | 0 | 0 | 0 |
5/11 | 0 | 0 | 0 | 0 |
6/11 | 0 | 0 | 0 | 0 |
7/11 | 0 | 0 | 0 | 0 |
8/11 | 0 | 0 | 0 | 0 |
9/11 | 0 | 0 | 0 | 0 |
10/11 | 0 | 0 | 0 | 0 |
11/11 | 0 | 0 | 0 | 0 |
12/11 | 0 | 0 | 0 | 0 |
1/12 | 0 | 0 | 0 | 0 |
2/12 | 0 | 0 | 0 | 0 |
3/12 | 0 | 0 | 0 | 0 |
4/12 | 0 | 0 | 0 | 0 |
5/12 | 0 | 0 | 0 | 0 |
6/12 | 0 | 0 | 0 | 0 |
7/12 | 0 | 0 | 0 | 0 |
8/12 | 0 | 0 | 0 | 0 |
9/12 | 0 | 0 | 0 | 0 |
10/12 | 0 | 0 | 0 | 0 |
11/12 | 0 | 0 | 0 | 0 |
12/12 | 0 | 0 | 0 | 0 |
[BACK]
Community content is available under CC-BY-SA unless otherwise noted.